Keri Chiodo

Dr. Keri Chiodo is a Senior Medical Science Liaison with Alkermes, supporting the company’s psychiatry portfolio across Florida. With over eight years of experience as an MSL, she brings deep expertise in scientific exchange, evidence translation, and stakeholder engagement within the psychiatry and mental health space.

Keri earned her PhD in Neuroscience from Wake Forest University, where her research focused on the neurobiology of substance use and pharmacological approaches to treating cocaine dependence. Her career spans academic research, science policy, science communication, and medical affairs, including roles at Teva Pharmaceuticals, the National Institute of Mental Health, the Association for Psychological Science, and the National Academies of Sciences, Engineering, and Medicine.

Keri is passionate about the MSL role as a bridge between scientific innovation and clinical practice. She is committed to advancing mental health care by educating healthcare providers and transforming clinical discussions into actionable insights that improve outcomes for people living with serious mental illness and addiction.